Pharma & Healthcare
Global Targeted Drugs for Parkinson's Disease Market Research Report 2026
- Feb 24, 26
- ID: 721064
- Pages: 97
- Figures: 90
- Views: 2
This report delivers a comprehensive overview of the global Targeted Drugs for Parkinson's Disease market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Targeted Drugs for Parkinson's Disease. The Targeted Drugs for Parkinson's Disease market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Targeted Drugs for Parkinson's Disease market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Targeted Drugs for Parkinson's Disease manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Acadia Pharmaceuticals Inc.
Kyowa Kirin
Supernus Pharmaceuticals
UCB
Sumitomo Pharma Co., Ltd.
Segment by Type
Capsule
Patch
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Targeted Drugs for Parkinson's Disease companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Targeted Drugs for Parkinson's Disease market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Targeted Drugs for Parkinson's Disease manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Acadia Pharmaceuticals Inc.
Kyowa Kirin
Supernus Pharmaceuticals
UCB
Sumitomo Pharma Co., Ltd.
Segment by Type
Capsule
Patch
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Targeted Drugs for Parkinson's Disease companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Drugs for Parkinson's Disease Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Capsule
1.2.3 Patch
1.2.4 Other
1.3 Market by Application
1.3.1 Global Targeted Drugs for Parkinson's Disease Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Drugs for Parkinson's Disease Market Perspective (2021–2032)
2.2 Global Targeted Drugs for Parkinson's Disease Growth Trends by Region
2.2.1 Global Targeted Drugs for Parkinson's Disease Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Targeted Drugs for Parkinson's Disease Historic Market Size by Region (2021–2026)
2.2.3 Targeted Drugs for Parkinson's Disease Forecasted Market Size by Region (2027–2032)
2.3 Targeted Drugs for Parkinson's Disease Market Dynamics
2.3.1 Targeted Drugs for Parkinson's Disease Industry Trends
2.3.2 Targeted Drugs for Parkinson's Disease Market Drivers
2.3.3 Targeted Drugs for Parkinson's Disease Market Challenges
2.3.4 Targeted Drugs for Parkinson's Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Drugs for Parkinson's Disease Players by Revenue
3.1.1 Global Top Targeted Drugs for Parkinson's Disease Players by Revenue (2021–2026)
3.1.2 Global Targeted Drugs for Parkinson's Disease Revenue Market Share by Players (2021–2026)
3.2 Global Top Targeted Drugs for Parkinson's Disease Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Targeted Drugs for Parkinson's Disease Revenue
3.4 Global Targeted Drugs for Parkinson's Disease Market Concentration Ratio
3.4.1 Global Targeted Drugs for Parkinson's Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Drugs for Parkinson's Disease Revenue in 2025
3.5 Global Key Players of Targeted Drugs for Parkinson's Disease Head Offices and Areas Served
3.6 Global Key Players of Targeted Drugs for Parkinson's Disease, Products and Applications
3.7 Global Key Players of Targeted Drugs for Parkinson's Disease, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Targeted Drugs for Parkinson's Disease Breakdown Data by Type
4.1 Global Targeted Drugs for Parkinson's Disease Historic Market Size by Type (2021–2026)
4.2 Global Targeted Drugs for Parkinson's Disease Forecasted Market Size by Type (2027–2032)
5 Targeted Drugs for Parkinson's Disease Breakdown Data by Application
5.1 Global Targeted Drugs for Parkinson's Disease Historic Market Size by Application (2021–2026)
5.2 Global Targeted Drugs for Parkinson's Disease Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Targeted Drugs for Parkinson's Disease Market Size (2021–2032)
6.2 North America Targeted Drugs for Parkinson's Disease Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Targeted Drugs for Parkinson's Disease Market Size by Country (2021–2026)
6.4 North America Targeted Drugs for Parkinson's Disease Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Drugs for Parkinson's Disease Market Size (2021–2032)
7.2 Europe Targeted Drugs for Parkinson's Disease Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Targeted Drugs for Parkinson's Disease Market Size by Country (2021–2026)
7.4 Europe Targeted Drugs for Parkinson's Disease Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Targeted Drugs for Parkinson's Disease Market Size (2021–2032)
8.2 Asia-Pacific Targeted Drugs for Parkinson's Disease Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Targeted Drugs for Parkinson's Disease Market Size by Region (2021–2026)
8.4 Asia-Pacific Targeted Drugs for Parkinson's Disease Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Targeted Drugs for Parkinson's Disease Market Size (2021–2032)
9.2 Latin America Targeted Drugs for Parkinson's Disease Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Targeted Drugs for Parkinson's Disease Market Size by Country (2021–2026)
9.4 Latin America Targeted Drugs for Parkinson's Disease Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size (2021–2032)
10.2 Middle East & Africa Targeted Drugs for Parkinson's Disease Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size by Country (2021–2026)
10.4 Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Acadia Pharmaceuticals Inc.
11.1.1 Acadia Pharmaceuticals Inc. Company Details
11.1.2 Acadia Pharmaceuticals Inc. Business Overview
11.1.3 Acadia Pharmaceuticals Inc. Targeted Drugs for Parkinson's Disease Introduction
11.1.4 Acadia Pharmaceuticals Inc. Revenue in Targeted Drugs for Parkinson's Disease Business (2021–2026)
11.1.5 Acadia Pharmaceuticals Inc. Recent Development
11.2 Kyowa Kirin
11.2.1 Kyowa Kirin Company Details
11.2.2 Kyowa Kirin Business Overview
11.2.3 Kyowa Kirin Targeted Drugs for Parkinson's Disease Introduction
11.2.4 Kyowa Kirin Revenue in Targeted Drugs for Parkinson's Disease Business (2021–2026)
11.2.5 Kyowa Kirin Recent Development
11.3 Supernus Pharmaceuticals
11.3.1 Supernus Pharmaceuticals Company Details
11.3.2 Supernus Pharmaceuticals Business Overview
11.3.3 Supernus Pharmaceuticals Targeted Drugs for Parkinson's Disease Introduction
11.3.4 Supernus Pharmaceuticals Revenue in Targeted Drugs for Parkinson's Disease Business (2021–2026)
11.3.5 Supernus Pharmaceuticals Recent Development
11.4 UCB
11.4.1 UCB Company Details
11.4.2 UCB Business Overview
11.4.3 UCB Targeted Drugs for Parkinson's Disease Introduction
11.4.4 UCB Revenue in Targeted Drugs for Parkinson's Disease Business (2021–2026)
11.4.5 UCB Recent Development
11.5 Sumitomo Pharma Co., Ltd.
11.5.1 Sumitomo Pharma Co., Ltd. Company Details
11.5.2 Sumitomo Pharma Co., Ltd. Business Overview
11.5.3 Sumitomo Pharma Co., Ltd. Targeted Drugs for Parkinson's Disease Introduction
11.5.4 Sumitomo Pharma Co., Ltd. Revenue in Targeted Drugs for Parkinson's Disease Business (2021–2026)
11.5.5 Sumitomo Pharma Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Drugs for Parkinson's Disease Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Capsule
1.2.3 Patch
1.2.4 Other
1.3 Market by Application
1.3.1 Global Targeted Drugs for Parkinson's Disease Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Drugs for Parkinson's Disease Market Perspective (2021–2032)
2.2 Global Targeted Drugs for Parkinson's Disease Growth Trends by Region
2.2.1 Global Targeted Drugs for Parkinson's Disease Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Targeted Drugs for Parkinson's Disease Historic Market Size by Region (2021–2026)
2.2.3 Targeted Drugs for Parkinson's Disease Forecasted Market Size by Region (2027–2032)
2.3 Targeted Drugs for Parkinson's Disease Market Dynamics
2.3.1 Targeted Drugs for Parkinson's Disease Industry Trends
2.3.2 Targeted Drugs for Parkinson's Disease Market Drivers
2.3.3 Targeted Drugs for Parkinson's Disease Market Challenges
2.3.4 Targeted Drugs for Parkinson's Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Drugs for Parkinson's Disease Players by Revenue
3.1.1 Global Top Targeted Drugs for Parkinson's Disease Players by Revenue (2021–2026)
3.1.2 Global Targeted Drugs for Parkinson's Disease Revenue Market Share by Players (2021–2026)
3.2 Global Top Targeted Drugs for Parkinson's Disease Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Targeted Drugs for Parkinson's Disease Revenue
3.4 Global Targeted Drugs for Parkinson's Disease Market Concentration Ratio
3.4.1 Global Targeted Drugs for Parkinson's Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Drugs for Parkinson's Disease Revenue in 2025
3.5 Global Key Players of Targeted Drugs for Parkinson's Disease Head Offices and Areas Served
3.6 Global Key Players of Targeted Drugs for Parkinson's Disease, Products and Applications
3.7 Global Key Players of Targeted Drugs for Parkinson's Disease, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Targeted Drugs for Parkinson's Disease Breakdown Data by Type
4.1 Global Targeted Drugs for Parkinson's Disease Historic Market Size by Type (2021–2026)
4.2 Global Targeted Drugs for Parkinson's Disease Forecasted Market Size by Type (2027–2032)
5 Targeted Drugs for Parkinson's Disease Breakdown Data by Application
5.1 Global Targeted Drugs for Parkinson's Disease Historic Market Size by Application (2021–2026)
5.2 Global Targeted Drugs for Parkinson's Disease Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Targeted Drugs for Parkinson's Disease Market Size (2021–2032)
6.2 North America Targeted Drugs for Parkinson's Disease Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Targeted Drugs for Parkinson's Disease Market Size by Country (2021–2026)
6.4 North America Targeted Drugs for Parkinson's Disease Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Drugs for Parkinson's Disease Market Size (2021–2032)
7.2 Europe Targeted Drugs for Parkinson's Disease Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Targeted Drugs for Parkinson's Disease Market Size by Country (2021–2026)
7.4 Europe Targeted Drugs for Parkinson's Disease Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Targeted Drugs for Parkinson's Disease Market Size (2021–2032)
8.2 Asia-Pacific Targeted Drugs for Parkinson's Disease Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Targeted Drugs for Parkinson's Disease Market Size by Region (2021–2026)
8.4 Asia-Pacific Targeted Drugs for Parkinson's Disease Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Targeted Drugs for Parkinson's Disease Market Size (2021–2032)
9.2 Latin America Targeted Drugs for Parkinson's Disease Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Targeted Drugs for Parkinson's Disease Market Size by Country (2021–2026)
9.4 Latin America Targeted Drugs for Parkinson's Disease Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size (2021–2032)
10.2 Middle East & Africa Targeted Drugs for Parkinson's Disease Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size by Country (2021–2026)
10.4 Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Acadia Pharmaceuticals Inc.
11.1.1 Acadia Pharmaceuticals Inc. Company Details
11.1.2 Acadia Pharmaceuticals Inc. Business Overview
11.1.3 Acadia Pharmaceuticals Inc. Targeted Drugs for Parkinson's Disease Introduction
11.1.4 Acadia Pharmaceuticals Inc. Revenue in Targeted Drugs for Parkinson's Disease Business (2021–2026)
11.1.5 Acadia Pharmaceuticals Inc. Recent Development
11.2 Kyowa Kirin
11.2.1 Kyowa Kirin Company Details
11.2.2 Kyowa Kirin Business Overview
11.2.3 Kyowa Kirin Targeted Drugs for Parkinson's Disease Introduction
11.2.4 Kyowa Kirin Revenue in Targeted Drugs for Parkinson's Disease Business (2021–2026)
11.2.5 Kyowa Kirin Recent Development
11.3 Supernus Pharmaceuticals
11.3.1 Supernus Pharmaceuticals Company Details
11.3.2 Supernus Pharmaceuticals Business Overview
11.3.3 Supernus Pharmaceuticals Targeted Drugs for Parkinson's Disease Introduction
11.3.4 Supernus Pharmaceuticals Revenue in Targeted Drugs for Parkinson's Disease Business (2021–2026)
11.3.5 Supernus Pharmaceuticals Recent Development
11.4 UCB
11.4.1 UCB Company Details
11.4.2 UCB Business Overview
11.4.3 UCB Targeted Drugs for Parkinson's Disease Introduction
11.4.4 UCB Revenue in Targeted Drugs for Parkinson's Disease Business (2021–2026)
11.4.5 UCB Recent Development
11.5 Sumitomo Pharma Co., Ltd.
11.5.1 Sumitomo Pharma Co., Ltd. Company Details
11.5.2 Sumitomo Pharma Co., Ltd. Business Overview
11.5.3 Sumitomo Pharma Co., Ltd. Targeted Drugs for Parkinson's Disease Introduction
11.5.4 Sumitomo Pharma Co., Ltd. Revenue in Targeted Drugs for Parkinson's Disease Business (2021–2026)
11.5.5 Sumitomo Pharma Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Targeted Drugs for Parkinson's Disease Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Capsule
Table 3. Key Players of Patch
Table 4. Key Players of Other
Table 5. Global Targeted Drugs for Parkinson's Disease Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Targeted Drugs for Parkinson's Disease Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Targeted Drugs for Parkinson's Disease Market Size by Region (US$ Million), 2021–2026
Table 8. Global Targeted Drugs for Parkinson's Disease Market Share by Region (2021–2026)
Table 9. Global Targeted Drugs for Parkinson's Disease Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Targeted Drugs for Parkinson's Disease Market Share by Region (2027–2032)
Table 11. Targeted Drugs for Parkinson's Disease Market Trends
Table 12. Targeted Drugs for Parkinson's Disease Market Drivers
Table 13. Targeted Drugs for Parkinson's Disease Market Challenges
Table 14. Targeted Drugs for Parkinson's Disease Market Restraints
Table 15. Global Targeted Drugs for Parkinson's Disease Revenue by Players (US$ Million), 2021–2026
Table 16. Global Targeted Drugs for Parkinson's Disease Market Share by Players (2021–2026)
Table 17. Global Top Targeted Drugs for Parkinson's Disease Players by Tier (Tier 1, Tier 2, and Tier 3), based on Targeted Drugs for Parkinson's Disease Revenue, 2025
Table 18. Ranking of Global Top Targeted Drugs for Parkinson's Disease Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Targeted Drugs for Parkinson's Disease Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Targeted Drugs for Parkinson's Disease, Headquarters and Area Served
Table 21. Global Key Players of Targeted Drugs for Parkinson's Disease, Products and Applications
Table 22. Global Key Players of Targeted Drugs for Parkinson's Disease, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Targeted Drugs for Parkinson's Disease Market Size by Type (US$ Million), 2021–2026
Table 25. Global Targeted Drugs for Parkinson's Disease Revenue Market Share by Type (2021–2026)
Table 26. Global Targeted Drugs for Parkinson's Disease Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Targeted Drugs for Parkinson's Disease Revenue Market Share by Type (2027–2032)
Table 28. Global Targeted Drugs for Parkinson's Disease Market Size by Application (US$ Million), 2021–2026
Table 29. Global Targeted Drugs for Parkinson's Disease Revenue Market Share by Application (2021–2026)
Table 30. Global Targeted Drugs for Parkinson's Disease Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Targeted Drugs for Parkinson's Disease Revenue Market Share by Application (2027–2032)
Table 32. North America Targeted Drugs for Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Targeted Drugs for Parkinson's Disease Market Size by Country (US$ Million), 2021–2026
Table 34. North America Targeted Drugs for Parkinson's Disease Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Targeted Drugs for Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Targeted Drugs for Parkinson's Disease Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Targeted Drugs for Parkinson's Disease Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Targeted Drugs for Parkinson's Disease Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Targeted Drugs for Parkinson's Disease Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Targeted Drugs for Parkinson's Disease Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Targeted Drugs for Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Targeted Drugs for Parkinson's Disease Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Targeted Drugs for Parkinson's Disease Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size by Country (US$ Million), 2027–2032
Table 47. Acadia Pharmaceuticals Inc. Company Details
Table 48. Acadia Pharmaceuticals Inc. Business Overview
Table 49. Acadia Pharmaceuticals Inc. Targeted Drugs for Parkinson's Disease Product
Table 50. Acadia Pharmaceuticals Inc. Revenue in Targeted Drugs for Parkinson's Disease Business (US$ Million), 2021–2026
Table 51. Acadia Pharmaceuticals Inc. Recent Development
Table 52. Kyowa Kirin Company Details
Table 53. Kyowa Kirin Business Overview
Table 54. Kyowa Kirin Targeted Drugs for Parkinson's Disease Product
Table 55. Kyowa Kirin Revenue in Targeted Drugs for Parkinson's Disease Business (US$ Million), 2021–2026
Table 56. Kyowa Kirin Recent Development
Table 57. Supernus Pharmaceuticals Company Details
Table 58. Supernus Pharmaceuticals Business Overview
Table 59. Supernus Pharmaceuticals Targeted Drugs for Parkinson's Disease Product
Table 60. Supernus Pharmaceuticals Revenue in Targeted Drugs for Parkinson's Disease Business (US$ Million), 2021–2026
Table 61. Supernus Pharmaceuticals Recent Development
Table 62. UCB Company Details
Table 63. UCB Business Overview
Table 64. UCB Targeted Drugs for Parkinson's Disease Product
Table 65. UCB Revenue in Targeted Drugs for Parkinson's Disease Business (US$ Million), 2021–2026
Table 66. UCB Recent Development
Table 67. Sumitomo Pharma Co., Ltd. Company Details
Table 68. Sumitomo Pharma Co., Ltd. Business Overview
Table 69. Sumitomo Pharma Co., Ltd. Targeted Drugs for Parkinson's Disease Product
Table 70. Sumitomo Pharma Co., Ltd. Revenue in Targeted Drugs for Parkinson's Disease Business (US$ Million), 2021–2026
Table 71. Sumitomo Pharma Co., Ltd. Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
Table 75. Authors List of This Report
List of Figures
Figure 1. Targeted Drugs for Parkinson's Disease Picture
Figure 2. Global Targeted Drugs for Parkinson's Disease Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Targeted Drugs for Parkinson's Disease Market Share by Type: 2025 vs 2032
Figure 4. Capsule Features
Figure 5. Patch Features
Figure 6. Other Features
Figure 7. Global Targeted Drugs for Parkinson's Disease Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Targeted Drugs for Parkinson's Disease Market Share by Application: 2025 vs 2032
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Other Case Studies
Figure 12. Targeted Drugs for Parkinson's Disease Report Years Considered
Figure 13. Global Targeted Drugs for Parkinson's Disease Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Targeted Drugs for Parkinson's Disease Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Targeted Drugs for Parkinson's Disease Market Share by Region: 2025 vs 2032
Figure 16. Global Targeted Drugs for Parkinson's Disease Market Share by Players in 2025
Figure 17. Global Targeted Drugs for Parkinson's Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Targeted Drugs for Parkinson's Disease Revenue in 2025
Figure 19. North America Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Targeted Drugs for Parkinson's Disease Market Share by Country (2021–2032)
Figure 21. United States Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Targeted Drugs for Parkinson's Disease Market Share by Country (2021–2032)
Figure 25. Germany Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Targeted Drugs for Parkinson's Disease Market Share by Region (2021–2032)
Figure 33. China Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Targeted Drugs for Parkinson's Disease Market Share by Country (2021–2032)
Figure 41. Mexico Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Targeted Drugs for Parkinson's Disease Market Share by Country (2021–2032)
Figure 45. Israel Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Acadia Pharmaceuticals Inc. Revenue Growth Rate in Targeted Drugs for Parkinson's Disease Business (2021–2026)
Figure 49. Kyowa Kirin Revenue Growth Rate in Targeted Drugs for Parkinson's Disease Business (2021–2026)
Figure 50. Supernus Pharmaceuticals Revenue Growth Rate in Targeted Drugs for Parkinson's Disease Business (2021–2026)
Figure 51. UCB Revenue Growth Rate in Targeted Drugs for Parkinson's Disease Business (2021–2026)
Figure 52. Sumitomo Pharma Co., Ltd. Revenue Growth Rate in Targeted Drugs for Parkinson's Disease Business (2021–2026)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Table 1. Global Targeted Drugs for Parkinson's Disease Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Capsule
Table 3. Key Players of Patch
Table 4. Key Players of Other
Table 5. Global Targeted Drugs for Parkinson's Disease Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Targeted Drugs for Parkinson's Disease Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Targeted Drugs for Parkinson's Disease Market Size by Region (US$ Million), 2021–2026
Table 8. Global Targeted Drugs for Parkinson's Disease Market Share by Region (2021–2026)
Table 9. Global Targeted Drugs for Parkinson's Disease Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Targeted Drugs for Parkinson's Disease Market Share by Region (2027–2032)
Table 11. Targeted Drugs for Parkinson's Disease Market Trends
Table 12. Targeted Drugs for Parkinson's Disease Market Drivers
Table 13. Targeted Drugs for Parkinson's Disease Market Challenges
Table 14. Targeted Drugs for Parkinson's Disease Market Restraints
Table 15. Global Targeted Drugs for Parkinson's Disease Revenue by Players (US$ Million), 2021–2026
Table 16. Global Targeted Drugs for Parkinson's Disease Market Share by Players (2021–2026)
Table 17. Global Top Targeted Drugs for Parkinson's Disease Players by Tier (Tier 1, Tier 2, and Tier 3), based on Targeted Drugs for Parkinson's Disease Revenue, 2025
Table 18. Ranking of Global Top Targeted Drugs for Parkinson's Disease Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Targeted Drugs for Parkinson's Disease Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Targeted Drugs for Parkinson's Disease, Headquarters and Area Served
Table 21. Global Key Players of Targeted Drugs for Parkinson's Disease, Products and Applications
Table 22. Global Key Players of Targeted Drugs for Parkinson's Disease, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Targeted Drugs for Parkinson's Disease Market Size by Type (US$ Million), 2021–2026
Table 25. Global Targeted Drugs for Parkinson's Disease Revenue Market Share by Type (2021–2026)
Table 26. Global Targeted Drugs for Parkinson's Disease Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Targeted Drugs for Parkinson's Disease Revenue Market Share by Type (2027–2032)
Table 28. Global Targeted Drugs for Parkinson's Disease Market Size by Application (US$ Million), 2021–2026
Table 29. Global Targeted Drugs for Parkinson's Disease Revenue Market Share by Application (2021–2026)
Table 30. Global Targeted Drugs for Parkinson's Disease Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Targeted Drugs for Parkinson's Disease Revenue Market Share by Application (2027–2032)
Table 32. North America Targeted Drugs for Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Targeted Drugs for Parkinson's Disease Market Size by Country (US$ Million), 2021–2026
Table 34. North America Targeted Drugs for Parkinson's Disease Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Targeted Drugs for Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Targeted Drugs for Parkinson's Disease Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Targeted Drugs for Parkinson's Disease Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Targeted Drugs for Parkinson's Disease Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Targeted Drugs for Parkinson's Disease Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Targeted Drugs for Parkinson's Disease Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Targeted Drugs for Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Targeted Drugs for Parkinson's Disease Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Targeted Drugs for Parkinson's Disease Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size by Country (US$ Million), 2027–2032
Table 47. Acadia Pharmaceuticals Inc. Company Details
Table 48. Acadia Pharmaceuticals Inc. Business Overview
Table 49. Acadia Pharmaceuticals Inc. Targeted Drugs for Parkinson's Disease Product
Table 50. Acadia Pharmaceuticals Inc. Revenue in Targeted Drugs for Parkinson's Disease Business (US$ Million), 2021–2026
Table 51. Acadia Pharmaceuticals Inc. Recent Development
Table 52. Kyowa Kirin Company Details
Table 53. Kyowa Kirin Business Overview
Table 54. Kyowa Kirin Targeted Drugs for Parkinson's Disease Product
Table 55. Kyowa Kirin Revenue in Targeted Drugs for Parkinson's Disease Business (US$ Million), 2021–2026
Table 56. Kyowa Kirin Recent Development
Table 57. Supernus Pharmaceuticals Company Details
Table 58. Supernus Pharmaceuticals Business Overview
Table 59. Supernus Pharmaceuticals Targeted Drugs for Parkinson's Disease Product
Table 60. Supernus Pharmaceuticals Revenue in Targeted Drugs for Parkinson's Disease Business (US$ Million), 2021–2026
Table 61. Supernus Pharmaceuticals Recent Development
Table 62. UCB Company Details
Table 63. UCB Business Overview
Table 64. UCB Targeted Drugs for Parkinson's Disease Product
Table 65. UCB Revenue in Targeted Drugs for Parkinson's Disease Business (US$ Million), 2021–2026
Table 66. UCB Recent Development
Table 67. Sumitomo Pharma Co., Ltd. Company Details
Table 68. Sumitomo Pharma Co., Ltd. Business Overview
Table 69. Sumitomo Pharma Co., Ltd. Targeted Drugs for Parkinson's Disease Product
Table 70. Sumitomo Pharma Co., Ltd. Revenue in Targeted Drugs for Parkinson's Disease Business (US$ Million), 2021–2026
Table 71. Sumitomo Pharma Co., Ltd. Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
Table 75. Authors List of This Report
List of Figures
Figure 1. Targeted Drugs for Parkinson's Disease Picture
Figure 2. Global Targeted Drugs for Parkinson's Disease Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Targeted Drugs for Parkinson's Disease Market Share by Type: 2025 vs 2032
Figure 4. Capsule Features
Figure 5. Patch Features
Figure 6. Other Features
Figure 7. Global Targeted Drugs for Parkinson's Disease Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Targeted Drugs for Parkinson's Disease Market Share by Application: 2025 vs 2032
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Other Case Studies
Figure 12. Targeted Drugs for Parkinson's Disease Report Years Considered
Figure 13. Global Targeted Drugs for Parkinson's Disease Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Targeted Drugs for Parkinson's Disease Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Targeted Drugs for Parkinson's Disease Market Share by Region: 2025 vs 2032
Figure 16. Global Targeted Drugs for Parkinson's Disease Market Share by Players in 2025
Figure 17. Global Targeted Drugs for Parkinson's Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Targeted Drugs for Parkinson's Disease Revenue in 2025
Figure 19. North America Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Targeted Drugs for Parkinson's Disease Market Share by Country (2021–2032)
Figure 21. United States Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Targeted Drugs for Parkinson's Disease Market Share by Country (2021–2032)
Figure 25. Germany Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Targeted Drugs for Parkinson's Disease Market Share by Region (2021–2032)
Figure 33. China Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Targeted Drugs for Parkinson's Disease Market Share by Country (2021–2032)
Figure 41. Mexico Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Targeted Drugs for Parkinson's Disease Market Share by Country (2021–2032)
Figure 45. Israel Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Targeted Drugs for Parkinson's Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Acadia Pharmaceuticals Inc. Revenue Growth Rate in Targeted Drugs for Parkinson's Disease Business (2021–2026)
Figure 49. Kyowa Kirin Revenue Growth Rate in Targeted Drugs for Parkinson's Disease Business (2021–2026)
Figure 50. Supernus Pharmaceuticals Revenue Growth Rate in Targeted Drugs for Parkinson's Disease Business (2021–2026)
Figure 51. UCB Revenue Growth Rate in Targeted Drugs for Parkinson's Disease Business (2021–2026)
Figure 52. Sumitomo Pharma Co., Ltd. Revenue Growth Rate in Targeted Drugs for Parkinson's Disease Business (2021–2026)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232